🔎 Trials Near Me

Home › Cardiovascular Disease › NCT06324981

Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors

Recruiting

Using Artificially Intelligent Text Messaging Technology to Improve American Heart Association's Life's Essential 8 Health Behaviors: LE8 Bot + Backup

Who can join

Ages 18 to 89 · All sexes

Full eligibility criteria
Inclusion Criteria:

* diagnosis of one or more of the following CV risk factors (i.e., hypertension, diabetes or hyperlipidemia); and
* the risk factor is at poor or intermediate health levels as defined by LE8 (e.g., BP\>140/90 mm Hg); and
* the patient exhibits poor adherence to prescribed medication to treat the CV risk factor as defined by a delay in refilling the medication within the past 6 months.

Exclusion Criteria:

* patients who do not have cellphone; or
* enrolled in hospice or palliative care; or
* Non-English or Spanish speaking; or
* enrolled in another clinical trial if denoted in the EHR.

About the study

The goal of our pragmatic clinical trial is to compare how well three different strategies might do to reduce risk factors for cardiovascular disease in patients experiencing health disparities. The three different strategies are: 1) text messages, 2) interactive chatbot messages, and 3) chatbot messages with proactive pharmacist support. To measure cardiovascular risk factors, the investigators are using the American Heart Association's Life's Essential 8 (LE8) factors-blood glucose, cholesterol, blood pressure, physical activity, body mass index, diet, and smoking.

This study focuses on improving cardiovascular risk factors for individuals facing health disparities, such as ethnic minorities, limited English proficiency, and low-income groups. These groups are more likely to be seriously affected by cardiovascular diseases. Self-management, or an individual's roles in managing their own chronic disease, includes lifestyle changes, medication adherence. Improving patients' self-management has been shown to improve health behaviors, better disease control and improved patient outcomes.

The main question this study aims to answer is if one of the strategies (texting, chatbot, or chatbot with pharmacist support) may improve patient self-management and patient outcomes.

The investigators will enroll up to 2,100 patients from three health systems that serve large populations experiencing health disparities: Denver Health, Salud Family Health Centers, and STRIDE Community Health Center.

The results might help researchers and health care systems find the best ways to involve patients with health disparities to managing their chronic cardiovascular disease.

What is being tested

Sponsor: University of Colorado, Denver · Participants: 2,100 · Started: Feb 26, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06324981

Locations in the U.S.

ColoradoDenver Health, Denver
Salud Family Health Centers, Fort Lupton (Not yet recruiting)
STRIDE Community Health Centers, Wheat Ridge (Not yet recruiting)

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.